Scientific environment



Download 391.79 Kb.
Page1/6
Date02.02.2017
Size391.79 Kb.
#14986
  1   2   3   4   5   6
Overall Component
10. Facilities & Other Resources:


SCIENTIFIC ENVIRONMENT


Overview: The Washington University Institute of Clinical and Translational Sciences (ICTS), has been funded by the Clinical and Translational Science Awards (CTSA) program of the National Center for Advancing Translational Sciences (NCATS) since 2007. ICTS is a transformative partnership between the School of Medicine and four other Washington University in St. Louis Schools, the College of Arts & Sciences, the George Warren Brown School of Social Work, and Schools of Engineering and Law; and BJC HealthCare, a large, nationally recognized, nonprofit health and integrated care delivery organization comprising Barnes-Jewish Hospital, the Goldfarb School of Nursing, and St. Louis Children’s Hospital. Since inception, partnership has included St. Louis College of Pharmacy and Saint Louis University, which are embedded within or located adjacent to the Washington University Medical School campus, easily accessed via the MetroLink light rail system. In 2015, a formal partnership was established with the University of Missouri-Columbia (MU), incorporating the School of Medicine, School of Journalism, Sinclair School of Nursing, and the Colleges of Engineering and Veterinary Medicine into our CTSA relationship. The ICTS is a catalyst for intra- and inter-institutional cooperation and through these collaborative relationships works to support the overarching goals of the national CTSA consortium and the ICTS mission.
Washington University in St. Louis (WU), founded in 1853, is a medium-sized, private research university with approximately 12,000 full-time students, half of whom are enrolled in graduate and professional programs, and nearly 2,100 part-time students. The diverse student body represents all 50 states, the District of Columbia, Guam, Puerto Rico, the Virgin Islands and more than 100 countries around the world, with approximately ninety percent of undergraduates derived from outside the state. With 30,000 applicants for 1,600 places in the freshman Class of 2016, the university’s undergraduate program was the 7th most selective in the nation, and the most recent U.S. News & World Report ranks WU 14th among national universities. For 2016, WU undergraduate and graduate programs in entrepreneurship have been recognized as among the top 25 in the United States by The Princeton Review and Entrepreneur magazine survey of more than 300 schools. This strength in entrepreneurial studies complements recent St. Louis recognition as among the best startup cities in the nation, evidenced in the CORTEX Innovation District (detailed below in Resources) and their 20 partners. The CORTEX Innovation District, bisected by MetroLink, is bounded by Saint Louis University to the east, and WU and St. Louis College of Pharmacy on the western border.
Washington University School of Medicine (WUSM) creates a world class scientific environment that brings strengths, efficiencies, and unique opportunities to the CTSA research community as a nexus to perform clinical and translational studies founded on established successes in research, education, and patient care. Since its founding in 1891, WUSM has trained nearly 9,000 physicians and has contributed groundbreaking discoveries in many areas of medical research. WUSM is internationally known for research in neuroscience, genetics, diabetes, cardiovascular diseases, oncology, immunology, diagnostic imaging, and many other specialty areas, which are supported through the ICTS infrastructure. WUSM was ranked #6 in 2015 by U.S. News & World Report among the nation’s research-oriented medical schools and currently has 1,983 full-time faculty members. In fiscal year 2014, WUSM received more than $353 million in grants from the National Institutes of Health (NIH), ranking as one of the top 5 academic institutions for NIH funding. WUSM has a longstanding commitment and track record in the training of investigators in basic sciences and clinical sciences extending to their pre-doctoral Medical Scientist Training Program (MSTP; MD/PhD) that accepts up to 20 of the nation’s most promising students per year.
The WUSM Faculty Practice Plan (FFP) is one of the largest integrated academic medical practices in the US with over 1360 physicians representing 76 specialties and subspecialties. WUSM physicians treat more than a million patients per year at Barnes-Jewish Hospital (BJH), St. Louis Children’s Hospital (SLCH), and The Rehabilitation Institute of St. Louis (detailed below). WUSM physicians also provide hospital-based care throughout the St. Louis metropolitan area at several off-campus facilities, including Barnes-Jewish West County Hospital, Barnes-Jewish St. Peter’s Hospital, Shriner’s Hospital, Missouri Baptist Medical Center, and Christian Hospital. All WUSM clinical practice sites participate in research, clinical trials, and training.
BJC HealthCare (BJC) system includes 13 community hospitals in Missouri and southern Illinois with 3,479 staffed beds, and is one of the largest academically-based health care systems in the country. The system serves regional residents through hospitals, seven nursing facilities, and includes The Rehabilitation Institute of St. Louis, a 96-bed inpatient rehabilitation hospital that offers comprehensive inpatient and outpatient rehabilitation services that are designed to return patients to leading active and independent lives. Barnes-Jewish Hospital (BJH) and St. Louis Children’s Hospital (SLCH) (detailed below) constitute the academic core of BJC. BJC is recognized for its ability to integrate health services in a cost-efficient manner, while providing an innovative medical data and imaging repository to enhance physicians’ access to patient data. BJC has more than 100 sites in the St. Louis metropolitan area for medical care and services, and is the dominant health care provider in the region with a 34 percent market share – more than double that of the next largest system. BJC is the first health care system in the nation to integrate an academic medical center with suburban, rural, and metropolitan-based health care facilities. Both BJH and SLCH are on the WUSM campus and serve as regional, national, and international referral centers, offering comprehensive care and providing a full range of health services and research for complex populations across the lifespan. The Goldfarb School of Nursing is set in an academic, clinical environment that includes two top 10, Magnet-status hospitals. Master of Science in Nursing degree programs prepare graduates to assume complex professional roles in advanced nursing practice, nursing education, or management and leadership. The Doctor of Nursing Practice/Doctor of Philosophy in Nursing (DNP/PhD) integrates practice and research aspects from both degrees through dynamic, integrated online coursework developed in collaboration with the Center for Lifelong Learning at the BJC Learning Institute. This program prepares graduates to become “practice scientists” and is the only program of its kind nationally. Goldfarb Hall, a 105,000 SF building on the Medical School Campus, is home to a Clinical Simulation Institute, and dedicated space for on-site faculty research.
Barnes-Jewish Hospital (BJH) is a 1,252-bed non-profit teaching hospital – the largest in Missouri. With a premier reputation in patient care, medical education, and community service, the hospital has been ranked among an elite group of the nation’s best academic hospitals on the U.S. News and World Report Honor Roll since 1993. BJH was ranked tenth in the 2015 U.S. News and World Report list of best hospitals; has a National Cancer Institute (NCI)-designated comprehensive cancer center, the Alvin J. Siteman Cancer Center (SCC) (detailed below) which received an “exceptional" rating in its 2015 renewal; and carries Magnet designation, the highest honor for excellence in nursing. The 1,800 member medical staff includes full-time faculty of WUSM, as well as private physicians. The medical staff is supported by a house staff of more than 900 residents and fellows, in addition to professional nurses and technicians, and service and support personnel. BJH is fully accredited by the Joint Commission on Accreditation of Healthcare Organizations and by the American College of Surgeons Commission on Cancer.
The Alvin J. Siteman Cancer Center (SCC) is an NCI-designated comprehensive cancer center housed in the Center for Advanced Medicine (CAM), a single-site, outpatient ambulatory care facility. SCC brings together over 350 WUSM, BJH, and SLCH physicians and researchers to comprise one of the nation’s leading medical research, teaching, and patient-care centers. SCC is the only NCI-designated cancer center in the state of Missouri, and the only NCI-designated cancer center within a 240-mile radius. Integration of all cancer-related activities under the authority of the SCC provides an effective administrative structure to promote novel interactive approaches to cancer research. SCC members hold approximately $130 million in cancer research funding, and WUSM physicians treat nearly 7,000 new cancer patients and follow more than 32,000 patients annually.

  • The SCC supports eight research programs in 1) prevention and control, 2) clinical and translational research, 3) genetics, 4) cellular proliferation, 5) developmental biology, 6) immunology, 7) stem cell biology and 8) imaging and ten resources shared with the ICTS and other entities.

  • The SCC comprises 107,422 SF and houses a 61-chair/bed infusion center, investigational pharmacy, clinical trials office, and multidisciplinary outpatient practices. All adult outpatients being treated for cancer are seen in this central facility, and the oncology inpatient floors are immediately adjacent to the outpatient floors dedicated for the SCC.

  • The Kling Center for Proton Therapy, launched in 2009, is the first implementation of a single vault proton therapy center and one of only six proton therapy centers in the U.S.

  • The SCC maintains a 2,615 SF FDA registered modern pharmaceutical cleanroom facility dedicated to the manufacture of custom biologics and drugs under current Good Manufacturing Practices (cGMP) conditions through the Biologic Therapeutics Center. This facility houses six (6) independent manufacturing suites (ISO Class 7, Class 10,000) with positive pressure to adjacent areas, equipped with biological safety cabinets and incubators, pass-through both sides, seamless cove base, intermediate entry rooms (Iso Class 8), separate gowning rooms (G1, G2), unidirectional traffic flow for personnel and materials and validated dual-door autoclave.

  • The SCC also provides patients with educational resources and support through a street-level Health and Cancer Information Center. The CAM has been designed to be a building within a building, having its own unique identity, lobby elevators and waiting areas and is located on the northern edge of the Medical School Campus.

  • The SCC supports one of only three NCI Specialized Programs of Research Excellence (SPORE) grants in the US that focus on leukemias and myelodysplastic syndromes. The SPORE is the cornerstone program of the National Cancer Institute’s effort to promote collaborative, interdisciplinary translational cancer research. The SCC SPORE also supports a Career Development Program to recruit and mentor new investigators in translational leukemia research and a Developmental Research Program to support innovative translational concepts.


St. Louis Children’s Hospital (SLCH) forms the focus of child health research, training, and education within the Medical School Campus. This 264-bed Pediatric hospital serves as the primary pediatric referral institution for individuals in the greater St. Louis population (~15,000 admissions/year; including over ~52,000 emergency unit visits/year). As part of a Campus Renewal Project concluding in 2016 (visualized left from Forest Park), SLCH will undergo a 100 bed expansion to consolidate and modernize the Women and Infants program and place labor and delivery close to the Neonatal Intensive Care Unit (NICU) , while providing leading-edge diagnostics and outpatient clinical space. As the largest pediatric hospital in Missouri, SLCH hospital currently maintains a 70-bed level III NICU, a 36-bed Pediatric Intensive Care Unit (PICU), and a 12 bed Cardiac Intensive Care Unit (CICU). All surgical subspecialties are represented, including pediatric cardiothoracic surgeons with special emphasis in lung transplantation. SLCH has been consistently ranked among the top Children’s Hospitals in the United States by U.S. News & World Report.
Saint Louis University (SLU), the first university founded west of the Mississippi River in 1818, has been an engaged CTSA partner since 2007. As a private institution, it has served as a major catalyst for urban renewal in St. Louis on its 271 acre campus located east of the Medical School Campus (adjacent to the CORTEX Innovation District). The SLU College for Public Health and Social Justice, Doisy College of Health Sciences, offering health care education at the baccalaureate, master’s, doctoral, and professional levels; Schools of Medicine and Nursing and the Albert Gnaegi Center for Health Care Ethics are ICTS partners for public health, health services, epidemiology, and health care ethics. The College for Public Health and Social Justice is a leader in community-based clinical research. U.S. News and World Report ranked the Master of Health Administration (MHA) program # 7, and the College for Public Health and Social Justice earned the # 23 spot in the 2016 Best Schools of Public Health rankings. Master of Public Health (MPH) and PhD degrees are offered in 6 concentration areas, with 60 faculty members involved in research projects covering a wide range of topics.

  • The Center for Vaccine Development at SLU Medical Center is a multi-disciplinary research center designed to conduct basic and clinical research on new vaccines and biologics. The Center occupies ~20,600 SF on the first floor of the Edward A. Doisy Research Center on the SLU Medical campus, completed in 2007 at a cost $82 million. The Vaccine Center aims to provide volunteer education to promote health and infectious disease prevention, and engage with the community to conduct trials in accordance with good clinical practices that will lead to decreases in health care costs through primary prevention of infectious disease. Nearly a dozen vaccine trials have been conducted or are currently active, several involving pediatric populations or older adults. The Center ranks among an elite group of nine Vaccine and Treatment Evaluation Units (VTEUs) eligible to bid on up to nearly $1 billion in NIH projects that will study protecting people from infectious diseases, including emerging threats. The SLU VTEU was recently awarded a five-year, $5.8 million contract from the NIH and the unit was designated as one of two in the country that have been designated by the National Institute of Allergy and Infectious Diseases to conduct -omics assessments on multiple potential vaccines to protect against infectious diseases.

  • The Center for World Health and Medicine (CWHM) was founded by a multidisciplinary team of former pharmaceutical company scientists at SLU in 2010 as a not-for-profit research center dedicated to the discovery and development of medicines to treat diseases that predominantly affect the world’s poor and underserved patient populations. CWHM partners with researchers at SLU and other collaborators around the world to overcome translational gaps in the pathway from early compound leads to true drug candidates. The CWHM is housed in the new Doisy Research Center in over 2,500 SF of laboratory space equipped with many former Pfizer research instruments.

Founded in 1864, St. Louis College of Pharmacy (STLCOP) is the 10th-largest college of pharmacy in the US. STLCOP is located on nine acres in the heart of one of the world’s finest biomedical and patient-care centers, immediately east of the Medical School Campus, where it forges active partnerships with nearby institutions such as WUSM, SLU, and Goldfarb School of Nursing. STLCOP stresses global prominence in pharmacy and health care education, interprofessional patient-centered care, and collaborative research.



  • STLCOP co-founded the Center for Interprofessional Education with Goldfarb School of Nursing and WUSM to jointly educate students in the health professions to provide evidence-based, patient-centered interprofessional care.

  • In a unique partnership announced in 2015, STLCOP and WUSM collaborated to create the Center for Clinical Pharmacology (CCP), designed to uncover better, safer, and more effective ways to use prescription medications to improve health. The CCP has five purpose-built laboratories occupying 12,000 SF in STLCOP’s new Academic and Research Building, located at Taylor and Duncan Avenues on the Medical School Campus.

The University of Missouri-Columbia (MU), founded in 1839 in Columbia, MO, is the flagship campus of the University of Missouri System. MU offers more than 280 degree programs among its 17 colleges and professional schools, and has a total enrollment of more than 32,000 students. MU is designated “Highest Research Activity” by the Carnegie Classification of Institutions of Higher Education, and is a member of the prestigious American Association of Universities (AAU). MU is a public institution that is one of only six universities nationwide with schools of medicine, veterinary medicine, law, engineering, agriculture, and a university hospital all on the same campus, and is one of only 13 universities with both an accredited school of medicine and an accredited college of veterinary medicine. As the first public university west of the Mississippi River, Columbia, midway between St. Louis and Kansas City, is a growing community with a population of more than 102,000. ICTS is partnering with five Schools and Colleges: the School of Medicine (SOM), School of Journalism, the Sinclair School of Nursing (SSON), and the Colleges of Engineering and Veterinary Medicine.



  • The School of Medicine (SOM) is a pioneer in the problem-based learning style of medical education that emphasizes problem solving, self-directed learning, and early clinical experience. In addition, the SOM Family Medicine Program ranked #7 in the U.S. News and World Report in 2015 and the Pre-Admissions Program and the Rural Track Program offered through the school give students an opportunity to gain education and experience practicing medicine in a rural area. A faculty of 100 basic scientists and 513 clinicians oversee the education and professional development of 392 medical students, 427 residents and fellows in 23 specialty programs, and 342 PhD and master’s degree candidates. Since 2000, more than 100,000 SF of medical laboratory space has been created at the Life Sciences Center and in labs for medical research through construction and renovation at the SOM, Truman Veterans Hospital and Dalton Cardiovascular Research Center. New buildings supporting medical research were completed in 2015 include MU's Biochemistry Complex, International Institute of Nano and Molecular Medicine, and Regional Biocontainment Laboratory. Radiopharmaceutical sciences is a signature program through the SOM, which supports biomolecular imaging and, through the MU-Research Reactor, provides the most powerful university research reactor and the largest producer of radioisotopes for biomedical and medical applications in the nation.

  • In 2007, the MU Institute for Clinical and Translational Science (iCATS) was established to provide an infrastructure for clinical and translational research, and bridge the gap between clinical and basic scientists. MU-iCATS is a campus-wide institute supported by twelve schools and colleges that is housed on the fifth floor of the Medical Science Building and aims to foster translational research by expanding the reach of basic science into clinical medicine. Under the authority of the MU Vice Chancellor for Research, MU-iCATS includes a state-of-the-art Clinical Research Center (CRC) that opened in 2012, as well as several support cores and services. iCATS is the focal point of MU's efforts to develop clinical and translational science programs that improve health through better research, education, and public service. By encouraging collaboration and sharing of resources through partnership with the WU Institute of Clinical and Translational Sciences (ICTS), these programs also improve innovation, productivity, and efficiency of our region.

  • The MU School of Journalism, formed in 1908, was the first school of professionalism journalism established in the world. Providing practical hands-on training in real-world news media and strategic communication agencies, the Journalism School aims to communicate the benefits of clinical and translational research to health care providers, policy makers, and communities through the Health Communication Research Center (HCRC). Supporting Health Literacy Missouri, the HCRC adopted evidence-based practices to create tailored stories with data and information specific for interests in each community with a media outlet (newspaper, radio or television station) that could be augmented with standard public relations practices to enhance local messaging within the community. In over two years of this targeted program, disseminated news stories were picked up more than 600 times by 123 different newspapers covering 86 Missouri counties, with nearly 90% of the features covered in rural areas.

  • The Sinclair School of Nursing (SSON) was rated as the top nursing school program in the country by CollegeAtlas.org in 2014, offering degree opportunities such as a bachelor’s degree, an online RN to BSN option, an accelerated BSN program, a master’s program, a Doctor of Nursing Practice (DNP), and a PhD degree. The DNP at SSOM received a 2015 Central Region Excellence Award for its on-line course programming, joining nine additional specialist nursing programs in distance learning initiatives offered by MU. The SSOM has been in the top 20 percent of nursing research institutions receiving NIH grant funding in three of the past four years. Since 2012, the SSON has held a $14.8 million grant from the U.S. Department of Health and Human Services Centers for Medicare and Medicaid Services (CMS) to reduce avoidable re-hospitalizations among nursing home residents and created the vision for TigerPlace (detailed below in Resources), a facility partnered with Americare and the College of Engineering that combines cutting-edge technology and current research to enable older adults to continue living longer in an assisted-living environment, a practice called Aging in Place (AIP).

  • Research programs in the MU College of Veterinary Medicine (MU-CVM) contribute to the advancement of science and significantly enhance the quality of professional education, including statewide leadership on the One Health initiative, a worldwide strategy for expanding interdisciplinary collaboration, education and communication in all aspects of health care that converge on animal and human health in the context of the environment. The Clinical Translational Science Award One Health Alliance (COHA) is comprised of veterinary schools partnered with medical and other colleagues through a NIH CTSA, aiming to advance understanding of diseases shared by humans and animals. The MU-CVM complex is made up of five buildings on the southeast corner of the MU campus: Connaway Hall, the Veterinary Diagnostic Laboratory, the Veterinary Medicine Building, the Veterinary Health Center (Clydesdale Hall), and the Veterinary Medical Science Building. The MU-CVM supports clinical trials through the Veterinary Health Center, which provides first access to proposed new treatments and studies to improve diagnosis or monitor disease in internal medicine, orthopaedics, neurology, and oncology medical services. The Companion Animal Clinic boasts one of the few veterinary medical cancer treatment programs in the country, mimicking the same cancer-fighting techniques and technology as in human hospitals. Cancer diagnosis is aided by use of a Spiral CT scanner and one of the few linear accelerators in the world dedicated to animal use.


The BJC Institute of Health (BJC-IH)/BioMed 21 The largest building ever constructed on the WUSM campus is the home base for BioMed 21 — the University's innovative research initiative designed to speed scientific discovery and apply breakthroughs to patient care rapidly. The BJC-IH building, supported by a $30 million gift from BJC, provides laboratory space for five newly created Interdisciplinary Research Centers of BioMed 21 and two academic departments at WUSM. The five Interdisciplinary Research Centers, which comprise WUSM researchers and ICTS members from a wide variety of fields, are devoted to cancer, cardiovascular disease, neurodegeneration, infectious diseases, and membrane excitability disorders, which encompass neural, cardiac, and other conditions. The High Throughput Screening Shared Resource, eligible for JIT funding, is located in BJC-IH.
The Institute for Public Health (IPH) is a university-wide initiative designed to transform our approach to public health and partnership with the community. Formed in 2008, the IPH brings together many disciplines and diverse partners to address the complex health issues facing the St. Louis region and the world. The IPH serves as a connector to public health at WU to amplify, improve, and support efforts across campus, within the local community, and around the world. The IPH is also a convener, bringing together faculty and students from diverse disciplines to share ideas, form community partnerships, and turn ideas into action. The vision for public health at WU is to improve community and international health through the creation of new knowledge, the application and translation of science, and the training of advanced academic and practice leaders in public health. The IPH includes diverse research centers with interests relevant to CTSA, Academy of Medicine (formerly IOM), and Agency for Healthcare Research and Quality (AHRQ) priority areas and vulnerable populations. IPH/ICTS faculty members have expertise in several relevant to the ICTS programs including communication science, health behavior, community-based research, health disparities, health policy, systems approaches, and implementation science supported through the following centers:

  • The Center for Community Health Partnerships and Research (CCHPR) (detailed below in Resources) was formed by merging the IPH Center for Community Health Partnerships and the ICTS Center for Community Engaged Research.

  • Center for Global Health and Infectious Disease (CGHID) was initiated in 2012 through support of the Departments of Medicine, Molecular Microbiology, and Pathology and Immunology. It serves as the hub for numerous initiatives related to global infectious diseases, built on a broad infectious diseases research portfolio that focuses on disease pathogenesis, immunology, pathogen genomics, as well as diagnosis and treatment. The CGHID aims to be recognized as an international authority in global infectious diseases by fostering a transdisciplinary program in education, research, and service that will make significant contributions to prevention and treatment of global infectious diseases, thereby improving the health and well-being of people throughout the world.

  • Harvey A. Friedman Center for Aging (detailed below in Resources) aims toward a global society where all older adults have maximum opportunity for health, security, and engagement. as described in the main Resources section.

  • Public Health Data and Training Center (detailed below in Resources) aims to put public health data into action by promoting its effective use in research, practice, and policy.

  • The Center for Health Economics and Policy (CHEP) encourages the development of evidence-based research focused on improving the health and dissemination of work to policymakers and other stakeholders. The CHEP provides seminar series charting impact evidence for Medicaid expansion under the Affordable Care Act and improving care for patients at high risk of hospitalization in a reforming health care system. Access to analytic tools that that support research in health economics and policy is provided in a succinct, accessible style, such as workshops on using restricted use Medical Expenditure Panel Survey (MEPS), a set of large-scale surveys of families and individuals, their medical providers, (doctors, hospitals, pharmacies, etc.), and employers across the United States.

  • The Center for Dissemination and Implementation seeks to ensure that the most effective services are delivered in health and public health settings, and provides support for the WU Network for Dissemination and Implementation Research (WUNDIR) (detailed separately in Resources) and two funding programs designed to support innovative projects focused on improving the dissemination and implementation of health interventions.

A major thrust of the Institute is event organization and programming focused on public health bringing together hundreds of students, faculty, staff, and St. Louis community members, and coordination of curriculum and program development and support to help strengthen public health education and research. Specific funding initiatives that ICTS-IPH investigators can access include the Public Health Cubed (PH3) program, a rapid seed funding mechanism designed to nurture novel ideas in public health research or education. Each faculty scholar contributes a virtual credit of $5,000 which can be cashed in with combined credits with a minimum of two other investigators to receive $15,000 funding. The PH3 program runs three cycles annually.

Resources availabe to the Institute of Clinical and Translational Sciences (ICTS)
WUSM was awarded a CTSA grant in 2007 (renewed in 2011) that enabled development of the Institute of Clinical and Translational Science (ICTS). The ICTS integrates pre- and post-doctoral training in clinical and translational research (detailed in the K and T submission) and research services throughout WU and partnering institutions. Forged through the merger of previous grants, the current award (UL1 TR000448) facilitates regional partnerships with academic, healthcare, community and scientific institutions and key research core resources to stimulate and facilitate the performance of safe and ethical interdisciplinary clinical and translational research and to provide an environment to train the next cadre of clinical and translational investigators. In concert with the National CTSA Consortium goals, the ICTS provides infrastructure (services, personnel, space, equipment), strategic funding and training in order to reduce the time it takes for laboratory discoveries to become treatments for patients.
Investigators are able to draw upon ICTS Cores and services for assistance during all phases of a clinical and translational research study, from protocol development to dissemination and implementation of results. Biostatistical, ethical and regulatory consultations and reviews are available to assist in early planning and protocol development. Pilot funding, participant recruitment services, access to specialized clinical research units, biospecimen banking and biomedical informatics expertise facilitate study implementation. Other ICTS programs are designed to assist in the publication of findings and/or connection to community and commercial partners. Cross-disciplinary clinical research training and career development for pre-doctoral students, house- staff, postdoctoral fellows and faculty, including specialized expertise to conduct studies in children, is also fundamental to the ICTS. Key resources are summarized below alphabetically.


Download 391.79 Kb.

Share with your friends:
  1   2   3   4   5   6




The database is protected by copyright ©ininet.org 2024
send message

    Main page